The latest data, issued in March, from antibody search engine CiteAb, based in Bath, UK suggests that the US has been losing its share of the biosciences market over the past 12 months. In February 2014, CiteAb released data suggesting that China would soon be claiming the lion's share of the global bioscience market, overtaking the US within 5-10 years. But Dr Andrew Chalmers, founder of CiteAb, said the latest data clearly shows that there has been a large spike in the number of Chinese research papers using antibodies over the last 12 months. Equally, the number of US papers has dropped significantly. This data acts as a good indicator of bioscience research activity.
展开▼
